Nothing Special   »   [go: up one dir, main page]

JPH07316131A - Production of pyrrole derivative - Google Patents

Production of pyrrole derivative

Info

Publication number
JPH07316131A
JPH07316131A JP11496794A JP11496794A JPH07316131A JP H07316131 A JPH07316131 A JP H07316131A JP 11496794 A JP11496794 A JP 11496794A JP 11496794 A JP11496794 A JP 11496794A JP H07316131 A JPH07316131 A JP H07316131A
Authority
JP
Japan
Prior art keywords
compound
lithium borohydride
useful
general formula
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11496794A
Other languages
Japanese (ja)
Inventor
Hisao Takayanagi
久男 高柳
Tadashi Shirasaka
正 白坂
Hiroshi Iwamura
寛 岩村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Priority to JP11496794A priority Critical patent/JPH07316131A/en
Publication of JPH07316131A publication Critical patent/JPH07316131A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrrole Compounds (AREA)

Abstract

PURPOSE:To easily obtain in high purity a pyrrole derivatlve at a low cost useful as an intermediate for synthesizing texaphyrins useful in the medicinal area, by reducing a diethylpyrrole derivative with lithium borohydride. CONSTITUTION:A compound of formula I (R is a 1-4C alkyl; ph is phenyl) is reduced with lithium borohydride in a solvent (e.g. THF) at -50 to 150 deg.C (pref. -20 to 100 deg.C) to obtain the objective compound of formula II. The amount of the lithium borohydride to be used is 0.1-20 (pref. 0.5-5)mol per mol of the compound of formula I. By this method, the objective pyrrole derivative can be produced without the need for using diborane, a highly toxic reducing agent. The texaphyrins derived from this pyrrole derivative, e.g. gadolinium texaphyrin, are useful as in vivo diagnostics.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医療分野において有用
な化合物であるテキサフィリン類の製造に有用な合成中
間体であるピロール誘導体の製造方法に関し、詳しくは
2,5−ビス[(ピロール−2−イル)メチル]ピロー
ル誘導体の製造方法に関する。
TECHNICAL FIELD The present invention relates to a process for producing a pyrrole derivative which is a synthetic intermediate useful for producing texaphyrins which are compounds useful in the medical field, and more specifically to 2,5-bis [(pyrrole-2 -Yl) methyl] pyrrole derivatives.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】テキ
サフィリンの金属錯体、例えばガドリニウムテキサフィ
リンは体内診断薬として有用である(Sessler,
etc.,J.Am.Chem.Soc.,115,1
0368(1993)、Sessler.etc.,A
cc.Chem.Res.,27,43(199
4))。この化合物は、下記一般式(II)で表される化
合物を中間体とするルートで合成できることが知られて
おり(Sessler,Inorg.Chem.,
,3175(1993))、更に下記一般式(II)の
化合物は、下記一般式(I)の化合物より合成されてい
る。この時、下記一般式(I)の化合物の2種類のエス
テル基を選択的に還元する必要があり、還元剤としてジ
ボランを使用している。しかし、ジボランは極めて毒性
が高い還元剤であるため、エステル基を選択的に還元す
るジボラン以外の還元剤が強く求められていた。
BACKGROUND OF THE INVENTION Metal complexes of texaphyrin, such as gadolinium texaphyrin, are useful as in-vivo diagnostic agents (Sessler,
etc. J. Am. Chem. Soc. , 115 , 1
0368 (1993), Sessler. etc. , A
cc. Chem. Res. , 27 , 43 (199
4)). It is known that this compound can be synthesized by a route using a compound represented by the following general formula (II) as an intermediate (Sessler, Inorg. Chem., 3
2 , 3175 (1993)), and the compound of the following general formula (II) is synthesized from the compound of the following general formula (I). At this time, it is necessary to selectively reduce two kinds of ester groups of the compound of the following general formula (I), and diborane is used as a reducing agent. However, since diborane is a highly toxic reducing agent, there has been a strong demand for reducing agents other than diborane that selectively reduce ester groups.

【0003】[0003]

【問題を解決するための手段】本発明者らは、毒性の低
い還元剤の開発を目的として鋭意検討を重ねた結果、水
素化ホウ素リチウムを使用するとジボランと同等にエス
テル基を選択的に還元できることを見出し本発明に到達
した。即ち、本発明の要旨は、下記一般式(I)
[Means for Solving the Problems] As a result of intensive studies aimed at developing a reducing agent having low toxicity, the present inventors have found that the use of lithium borohydride selectively reduces an ester group in the same manner as diborane. The inventors have found what can be done and have reached the present invention. That is, the gist of the present invention is the general formula (I)

【0004】[0004]

【化3】 [Chemical 3]

【0005】(上記式中で、RはC1〜C4のアルキル基
を表し、phはフェニル基を表す。)で表される化合物
を水素化ホウ素リチウムで還元させることを特徴とする
下記一般式(II)
(In the above formula, R represents a C 1 -C 4 alkyl group and ph represents a phenyl group.) A compound represented by the following general formula characterized by reducing with lithium borohydride Formula (II)

【0006】[0006]

【化4】 [Chemical 4]

【0007】で表されるピロール誘導体の製造方法に存
する。以下、本発明につき詳細に説明する。上記一般式
(I)中のRとしてはメチル基、エチル基、n−プロピ
ル基、イソプロピル基、n−ブチル基等のC1〜C4のア
ルキル基が挙げられる。本発明で用いられる水素化ホウ
素リチウムとしては市販品を用いることができるが、さ
らに経済的に反応を行うには、反応系中で水素化ホウ素
ナトリウムあるいは水素化ホウ素カリウムに塩化リチウ
ム、臭化リチウム、ヨウ化リチウム等のリチウム塩を作
用させ水素化ホウ素リチウムを調製することも可能であ
る。リチウム塩は水素化ホウ素ナトリウム等の金属水素
錯化合物に対して0.1〜10モル当量、好ましくは
0.5〜2モル当量使用する。反応系中で、水素化ホウ
素リチウムを生成させる場合、水素化ホウ素リチウムを
あらかじめ生成させた後、上記一般式(I)の化合物を
反応させる方法、または、上記一般式(I)の化合物の
存在下、金属錯化合物にリチウム塩を作用させる方法の
どちらでもかまわない。水素化ホウ素リチウムの必要量
は、上記一般式(I)の化合物に対し0.1〜20モル
当量、好ましくは0.5〜5モル当量程度である。
The method is for producing a pyrrole derivative represented by Hereinafter, the present invention will be described in detail. Examples of R in the general formula (I) include C 1 to C 4 alkyl groups such as a methyl group, an ethyl group, an n-propyl group, an isopropyl group, and an n-butyl group. As the lithium borohydride used in the present invention, commercially available products can be used, but in order to carry out the reaction more economically, sodium borohydride or potassium borohydride is added to lithium chloride or lithium bromide in the reaction system. It is also possible to prepare lithium borohydride by reacting a lithium salt such as lithium iodide. The lithium salt is used in an amount of 0.1 to 10 molar equivalents, preferably 0.5 to 2 molar equivalents, based on the metal hydrogen complex compound such as sodium borohydride. When lithium borohydride is produced in the reaction system, a method of reacting the compound of the above general formula (I) after previously producing lithium borohydride, or the presence of the compound of the above general formula (I) It does not matter whether the metal complex compound is reacted with a lithium salt. The required amount of lithium borohydride is 0.1 to 20 molar equivalents, preferably about 0.5 to 5 molar equivalents, with respect to the compound of the general formula (I).

【0008】反応溶媒としては反応に悪い影響を与えな
ければ特に制限されないが、ジエチルエテ−ル、テトラ
ヒドロフラン、n−ヘキサン、ベンゼン、トルエン、エ
タノール、イソプロパノール等が使用できる。反応温度
は−50〜150℃の範囲、好ましくは−20〜100
℃の範囲である。こうして得られた粗組成物は再結晶、
カラムクロマトグラフィー等により精製できる。
The reaction solvent is not particularly limited as long as it does not adversely affect the reaction, and diethyl ether, tetrahydrofuran, n-hexane, benzene, toluene, ethanol, isopropanol and the like can be used. The reaction temperature is in the range of -50 to 150 ° C, preferably -20 to 100.
It is in the range of ° C. The crude composition thus obtained is recrystallized,
It can be purified by column chromatography or the like.

【0009】[0009]

【実施例】以下、本発明を実施例により更に詳細に説明
するが、本発明はその要旨を越えない限り以下の実施例
により限定されるものではない。 実施例1 水素化ホウ素リチウム(22.7mg、1.0mmo
l)のテトラヒドロフラン(THF)懸濁液(2ml)
に、2,5−ビス[(5−ベンジルオキシカルボニル−
3−メトキシカルボニルエチル−4−メチルピロール−
2−イル)メチル]−3,4−ジエチルピロール(一般
式(I)の化合物,R=Me)(141mg、0.19
mmol)を加え、40℃で4時間加熱撹拌した。反応
液を冷却後、飽和食塩水を加え、酢酸エチルで抽出し
た。有機層を炭酸カリウムで乾燥後、濾過し溶媒を留去
することにより2,5−ビス[(5−ベンジルオキシカ
ルボニル−3−(3−ヒドロキシプロピル)−4−メチ
ルピロール−2−イル)メチル]−3,4−ジエチルピ
ロール(一般式(II)の化合物)(118mg、収率8
4%)を得た。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the following examples unless it exceeds the gist thereof. Example 1 Lithium borohydride (22.7 mg, 1.0 mmo
1) tetrahydrofuran (THF) suspension (2 ml)
2,5-bis [(5-benzyloxycarbonyl-
3-methoxycarbonylethyl-4-methylpyrrole-
2-yl) methyl] -3,4-diethylpyrrole (compound of general formula (I), R = Me) (141 mg, 0.19
mmol) was added and the mixture was heated with stirring at 40 ° C. for 4 hours. The reaction solution was cooled, saturated brine was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over potassium carbonate, filtered, and the solvent was evaporated to remove 2,5-bis [(5-benzyloxycarbonyl-3- (3-hydroxypropyl) -4-methylpyrrol-2-yl) methyl. ] -3,4-diethylpyrrole (compound of general formula (II)) (118 mg, yield 8)
4%).

【0010】1H−NMR 1.11(6H,t,J=7.5Hz,CH2CH3
1.57−1.61(m,4H,CH2CH2CH2
H) 2.24(6H,S,Pyrr−CH3 2.41−2.48(8H,m,CH2CH3 and
CH2CH2CH2OH) 3. 51(4H,t,J=6.0Hz) 3.75
(4H,S,Pyrr) 2−CH2) 4.99(4H,
S,C65−CH2) 7.17−7.40(10H,
m) 8.52(S,1H,NH) 9.44(S,2
H,NH)
[0010]1H-NMR 1.11 (6H, t, J = 7.5Hz, CH2CH3)
1.57-1.61 (m, 4H, CH2CH2CH2O
H) 2.24 (6H, S, Pyrr-CH3)  2.41-2.48 (8H, m, CH2CH3 and
CH2CH2CH2OH)  3. 51 (4H, t, J = 6.0 Hz) 3.75
(4H, S, Pyrr) 2-CH2) 4.99 (4H,
S, C6HFive-CH2) 7.17-7.40 (10H,
m) 8.52 (S, 1H, NH) 9.44 (S, 2)
H, NH)

【0011】実施例2 窒素雰囲気下、水素化ホウ素カリウム(54.6mg,
1.0mmol)と塩化リチウム(43.4mg,1.
0mmol)のTHF懸濁液(2ml)を室温で4時間
撹拌させ、反応液中に水素化ホウ素リチウムを生成させ
た後、一般式(I)の化合物(R=Me)(149.8
mg,0.2mmol)を加え、1.5時間加熱還流し
た。実施例1の方法と同様に後処理をすることにより、
一般式(II)の化合物(137.5mg,収率99%)
を得た。
Example 2 Potassium borohydride (54.6 mg, under a nitrogen atmosphere)
1.0 mmol) and lithium chloride (43.4 mg, 1.
A THF suspension (2 ml) of 0 mmol) was stirred at room temperature for 4 hours to generate lithium borohydride in the reaction solution, and then the compound of general formula (I) (R = Me) (149.8).
(mg, 0.2 mmol) was added and the mixture was heated under reflux for 1.5 hours. By performing the post-treatment in the same manner as in the method of Example 1,
Compound of general formula (II) (137.5 mg, yield 99%)
Got

【0012】実施例3 窒素雰囲気下、水素化ホウ素カリウム(52.1mg,
1.0mmol)、塩化リチウム(42.5mg,1.
0mmol)のTHF懸濁液(2ml)、および一般式
(I)の化合物(R=Me)(140.7mg,0.1
9mmol)を混合し、40℃で6時間加熱撹拌した。
実施例1の方法と同様に後処理をすることにより、一般
式(II)の化合物(122.2mg,収率93%)を得
た。
Example 3 Potassium borohydride (52.1 mg,
1.0 mmol), lithium chloride (42.5 mg, 1.
0 mmol) in THF (2 ml), and a compound of general formula (I) (R = Me) (140.7 mg, 0.1
(9 mmol) was mixed, and the mixture was heated with stirring at 40 ° C. for 6 hours.
Post-treatment was carried out in the same manner as in the method of Example 1 to obtain a compound of the general formula (II) (122.2 mg, yield 93%).

【0013】[0013]

【発明の効果】本発明の方法によれば、医療分野等で有
用な化合物であるテキサフィリン類の合成中間体として
有用なピロール誘導体を、毒性が高いジボランを使用す
ることなく、容易かつ安価な製造方法にて高純度に製造
できる。
Industrial Applicability According to the method of the present invention, a pyrrole derivative useful as a synthetic intermediate for texaphyrins, which is a compound useful in the medical field and the like, can be easily and inexpensively produced without using highly toxic diborane. It can be produced in high purity by the method.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(I) 【化1】 (上記式中で、RはC1〜C4のアルキル基を表し、ph
はフェニル基を表す。)で表される化合物を水素化ホウ
素リチウムで還元させることを特徴とする下記一般式
(II) 【化2】 で表されるピロール誘導体の製造方法。
1. The following general formula (I): (In the above formula, R represents a C 1 -C 4 alkyl group, and ph
Represents a phenyl group. ) A compound represented by the following general formula (II), which is characterized by reducing with lithium borohydride. The manufacturing method of the pyrrole derivative represented by.
JP11496794A 1994-05-27 1994-05-27 Production of pyrrole derivative Pending JPH07316131A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11496794A JPH07316131A (en) 1994-05-27 1994-05-27 Production of pyrrole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11496794A JPH07316131A (en) 1994-05-27 1994-05-27 Production of pyrrole derivative

Publications (1)

Publication Number Publication Date
JPH07316131A true JPH07316131A (en) 1995-12-05

Family

ID=14651069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11496794A Pending JPH07316131A (en) 1994-05-27 1994-05-27 Production of pyrrole derivative

Country Status (1)

Country Link
JP (1) JPH07316131A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159669A1 (en) * 2016-03-15 2017-09-21 塩野義製薬株式会社 Method for producing phenoxyethanol derivative

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159669A1 (en) * 2016-03-15 2017-09-21 塩野義製薬株式会社 Method for producing phenoxyethanol derivative
CN108137457A (en) * 2016-03-15 2018-06-08 盐野义制药株式会社 The manufacturing method of Phenoxyethanol derivative
KR20180122330A (en) * 2016-03-15 2018-11-12 시오노기 앤드 컴파니, 리미티드 Process for producing phenoxyethanol derivative
US20190084910A1 (en) * 2016-03-15 2019-03-21 Shionogi & Co., Ltd.[ Method for Producing Phenoxyethanol Derivative
US10472312B2 (en) 2016-03-15 2019-11-12 Shionogi & Co., Ltd. Method for producing phenoxyethanol derivative
EA039048B1 (en) * 2016-03-15 2021-11-26 Сионоги Энд Ко., Лтд. Method for producing phenoxyethanol derivatives
CN108137457B (en) * 2016-03-15 2022-09-06 盐野义制药株式会社 Method for producing phenoxyethanol derivative

Similar Documents

Publication Publication Date Title
WO2020016749A2 (en) Chemical process for preparing phenylpiperidinyl indole derivatives
JPH0623150B2 (en) Process for producing optically active 3-hydroxybutanoic acids
CN115298199A (en) Preparation of cyclosporin derivatives
WO2012121079A1 (en) Compound and method for producing same, as well as method for producing oseltamivir phosphate
JPH07316131A (en) Production of pyrrole derivative
CN114573512B (en) Method for synthesizing C2-difluoro alkyl benzimidazole derivative
JP3046258B2 (en) Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
JPS5838261A (en) Novel 1,3-disubstituted imidazole derivative and its preparation
WO2024126771A1 (en) Process for preparing (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile
JPS6332359B2 (en)
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
US5041577A (en) Organogermanium compounds, processes for producing the same, and agent for inhibiting the activity of opioid peptide-degrading enzyme
KR100594568B1 (en) New synthetic process of aminolevlunic acid derivatives
JP4004082B2 (en) Method for producing cyclic nitroguanidine derivatives
KR20090099237A (en) Process for the preparation of 2-sulfonyliminoindoline using cu catalyst
JP2963983B2 (en) Cyclic .BETA.-ketothioamide derivatives
JP3863956B2 (en) Novel process for producing phosphonic acid diesters
JPH03264557A (en) Fluorine-containing compound
JPS58216160A (en) Production of quinoline derivative
JPH0399037A (en) Production of optically active carboxylic acid ester
JPH01319496A (en) Uracil derivative
JPH0434986B2 (en)
JP2001328993A (en) Optically active phosphine compound
JPH05148248A (en) Cyclic carbamate derivative, its production and its use
JPH07324072A (en) Production of 3,4-dialkylpyrrole